Jeremy Steven Davis - 21 Feb 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: SVP Chief Commercial Officer
Signature: /s/ Jeremy Davis
Issuer symbol: LAB
Transactions as of: 21 Feb 2023
Net transactions value: -$12,537
Form type: 4
Filing time: 23 Feb 2023, 20:45:13 UTC
Previous filing: 20 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Options Exercise	$0	+20,833		$0.000000	20,833	21 Feb 2023	Direct
transaction	LAB	Common Stock	Tax liability	$12,537	-6,176	-30%	$2.03	14,657	21 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LAB	Restricted Stock Units	Options Exercise	$0	-20,833	-8.3%	$0.000000	229,167	21 Feb 2023	Common Stock	20,833		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2	On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.